Thermo Fisher Scientific Acquires Prionics

Founded in 1997, Prionics is headquartered in Zurich, Switzerland, and has a major production facility in Lelystad, the Netherlands. Prionics’ product line of more than 50 diagnostic test kits, accessories and biochemicals expands the portfolio of animal health testing products under the Life Technologies brand.

“Prionics adds a unique blend of expertise and diagnostic solutions to new and existing customers,” said Kirk Adams, Ph.D., global animal health leader. “Improved accessibility to animal testing benefits both veterinarians and livestock producers.”

“Combining Prionics under the Life Technologies’ brand is certainly a win-win, since the products and capabilities are highly complementary,” said Dr. Markus Moser, CEO of Prionics. “We believe this will have a strong and worldwide impact on the animal health industry.”

Prionics brings a state-of-the-art infrastructure along with a certified tuberculin manufacturing facility, plus additional enzyme-linked immunosorbent assays (ELISA) under the Life Technologies brand.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $17 billion and 50,000 employees in 50 countries.

About Prionics
Based in Zurich, Switzerland, Prionics is one of the world’s leading providers of farm animal diagnostic solutions and is a recognized center of expertise in BSE and prion diseases. Founded in 1997 as a spin-off from Zurich University, Prionics researches and markets innovative diagnostic solutions for major farm animal diseases, thereby making a major contribution to the protection of consumer health. Around the year 2000 the start-up got famous for its BSE test kits.

In 2005, Prionics acquired Pfizer Animal Health’s diagnostic portfolio and, in 2006, entered into a strategic partnership with the Animal Science Group of the University of Wageningen (Netherlands). Winner of the Swiss Economic Award for “Company of the year” (2002) and the European Biotech Award for “Excellence in Biotech Business” (2004), in 2006 Prionics was nominated as the world’s best animal health company.